{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:50:26Z","timestamp":1792799426865,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A1515140038"],"award-info":[{"award-number":["2022A1515140038"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2023A1515140046"],"award-info":[{"award-number":["2023A1515140046"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U22A20525"],"award-info":[{"award-number":["U22A20525"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.intimp.2026.116264","type":"journal-article","created":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:44:40Z","timestamp":1769906680000},"page":"116264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A novel mi3 VLP nanoparticle vaccine displaying ESAT-6 -PPE57 -PPE68 -EsxV antigens exhibits superior immunogenicity and Mycobacterium tuberculosis growth inhibition"],"prefix":"10.1016","volume":"173","author":[{"given":"Qi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfeng","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Aiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sihui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialou","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaisong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangxian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10481","key":"10.1016\/j.intimp.2026.116264_bb0005","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S0140-6736(24)02479-6","volume":"405","author":"Trajman","year":"2025","journal-title":"Tuberculosis. Lancet"},{"issue":"Pt A","key":"10.1016\/j.intimp.2026.116264_bb0010","article-title":"Wnt5a regulates autophagy in Bacille Calmette-Gu\u00e9rin (BCG)-infected pulmonary epithelial cells","volume":"173","author":"Chen","year":"2022","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.intimp.2026.116264_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.107325","article-title":"Insights from the 2024 WHO global tuberculosis report - more comprehensive action, innovation, and investments required for achieving WHO end TB goals","volume":"150","author":"Goletti","year":"2025","journal-title":"Int. J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.intimp.2026.116264_bb0020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12967-023-03944-8","article-title":"BCG-induced trained immunity: history, mechanisms and potential applications","volume":"21","author":"Chen","year":"2023","journal-title":"J. Transl. Med."},{"issue":"12","key":"10.1016\/j.intimp.2026.116264_bb0025","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1080\/21645515.2021.2007711","article-title":"BCG vaccination strategies against tuberculosis: updates and perspectives","volume":"17","author":"Qu","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.intimp.2026.116264_bb0030","article-title":"Mycobacterium tuberculosis antigen Rv1471 induces innate immune memory and adaptive immunity against infection","author":"Huang","year":"2024","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.intimp.2026.116264_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112811","article-title":"A multistage protein subunit vaccine as BCG-booster confers protection against mycobacterium tuberculosis infection in murine models","volume":"139","author":"Chen","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116264_bb0040","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1038\/s41467-021-26934-0","article-title":"A mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Gu\u00e9rin","volume":"12","author":"Woodworth","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2026.116264_bb0045","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/s41541-023-00666-2","article-title":"A protective, single-visit TB vaccination regimen by co-administration of a subunit vaccine with BCG","volume":"8","author":"Dijkman","year":"2023","journal-title":"NPJ Vaccines"},{"issue":"1","key":"10.1016\/j.intimp.2026.116264_bb0050","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2300463","article-title":"A multistage Sendai virus vaccine incorporating latency-associated antigens induces protection against acute and latent tuberculosis","volume":"13","author":"Hu","year":"2024","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.intimp.2026.116264_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117594","article-title":"Tuberculosis vaccine: a journey from BCG to present","volume":"252","author":"Fatima","year":"2020","journal-title":"Life Sci."},{"issue":"10","key":"10.1016\/j.intimp.2026.116264_bb0060","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1080\/14760584.2021.1984890","article-title":"Nanovaccine: an emerging strategy","volume":"20","author":"Das","year":"2021","journal-title":"Expert Rev. Vaccines"},{"issue":"1","key":"10.1016\/j.intimp.2026.116264_bb0065","article-title":"Harnessing nanoparticles for immunomodulation and vaccines","volume":"5","author":"Gomes","year":"2017","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.intimp.2026.116264_bb0070","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/s12951-023-02210-9","article-title":"A candidate nanoparticle vaccine comprised of multiple epitopes of the African swine fever virus elicits a robust immune response","volume":"21","author":"Song","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116264_bb0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12951-025-03191-7","article-title":"RBD-displaying OMV nanovaccine boosts immunity against SARS-CoV-2","volume":"23","author":"Feng","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116264_bb0080","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41467-020-20654-7","article-title":"A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses","volume":"12","author":"Tan","year":"2021","journal-title":"Nat. Commun."},{"issue":"7762","key":"10.1016\/j.intimp.2026.116264_bb0085","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/s41586-019-1250-z","article-title":"Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques","volume":"570","author":"Escolano","year":"2019","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.intimp.2026.116264_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247963","article-title":"Construction, characterization, and immunization of nanoparticles that display a diverse array of influenza HA trimers","volume":"16","author":"Cohen","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.intimp.2026.116264_bb0095","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41541-024-00891-3","article-title":"Nanoparticle display of neuraminidase elicits enhanced antibody responses and protection against influenza a virus challenge","volume":"9","author":"Pascha","year":"2024","journal-title":"NPJ Vaccines"},{"issue":"9","key":"10.1016\/j.intimp.2026.116264_bb0100","doi-asserted-by":"crossref","first-page":"8855","DOI":"10.1021\/acsnano.8b02805","article-title":"Engineering a rugged Nanoscaffold to enhance plug-and-display vaccination","volume":"12","author":"Bruun","year":"2018","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.intimp.2026.116264_bb0105","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jmb.2013.10.021","article-title":"Structural analysis and optimization of the covalent association between SpyCatcher and a peptide tag","volume":"426","author":"Li","year":"2014","journal-title":"J. Mol. Biol."},{"issue":"9","key":"10.1016\/j.intimp.2026.116264_bb0110","article-title":"Development of a two-component nanoparticle vaccine displaying an HIV-1 envelope glycoprotein that elicits tier 2 Neutralising antibodies","volume":"12","author":"Malebo","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.intimp.2026.116264_bb0115","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1038\/s41467-024-50296-y","article-title":"Engineered reversible inhibition of SpyCatcher reactivity enables rapid generation of bispecific antibodies","volume":"15","author":"Hentrich","year":"2024","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.intimp.2026.116264_bb0120","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1021\/acsnano.0c08379","article-title":"Rapid development of SARS-CoV-2 spike protein receptor-binding domain self-assembled nanoparticle vaccine candidates","volume":"15","author":"Kang","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.intimp.2026.116264_bb0125","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.3389\/fimmu.2019.02139","article-title":"Regulatory T cells in mycobacterium tuberculosis infection","volume":"10","author":"Cardona","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116264_bb0130","article-title":"Advances in protein subunit vaccines against tuberculosis","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116264_bb0135","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41541-017-0027-3","article-title":"Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFN\u03b3 response promoting vaccine immunogenicity","volume":"2","author":"Coccia","year":"2017","journal-title":"NPJ Vaccines"},{"issue":"9","key":"10.1016\/j.intimp.2026.116264_bb0140","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1172\/JCI128877","article-title":"Targeting innate immunity for tuberculosis vaccination","volume":"129","author":"Khader","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"25","key":"10.1016\/j.intimp.2026.116264_bb0145","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMoa1909953","article-title":"Final analysis of a trial of M72\/AS01(E) vaccine to prevent tuberculosis","volume":"381","author":"Tait","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.intimp.2026.116264_bb0150","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.tube.2014.04.004","article-title":"Innate cytokine profiling of bovine alveolar macrophages reveals commonalities and divergence in the response to Mycobacterium bovis and mycobacterium tuberculosis infection","volume":"94","author":"Magee","year":"2014","journal-title":"Tuberculosis (Edinb.)"},{"issue":"1","key":"10.1016\/j.intimp.2026.116264_bb0155","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41541-024-00906-z","article-title":"A modified mycobacterial growth inhibition assay for the functional assessment of vaccine-mediated immunity","volume":"9","author":"Vergara","year":"2024","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.intimp.2026.116264_bb0160","doi-asserted-by":"crossref","first-page":"257","DOI":"10.12688\/f1000research.51640.1","article-title":"The in vitro direct mycobacterial growth inhibition assay (MGIA) for the early evaluation of TB vaccine candidates and assessment of protective immunity: a protocol for non-human primate cells","volume":"10","author":"Tanner","year":"2021","journal-title":"F1000Res"},{"issue":"8","key":"10.1016\/j.intimp.2026.116264_bb0165","article-title":"Next-generation TB vaccines: Progress, challenges, and prospects","volume":"11","author":"Zhuang","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"11","key":"10.1016\/j.intimp.2026.116264_bb0170","doi-asserted-by":"crossref","first-page":"7948","DOI":"10.4049\/jimmunol.181.11.7948","article-title":"Identification of human T cell antigens for the development of vaccines against mycobacterium tuberculosis","volume":"181","author":"Bertholet","year":"2008","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116264_bb0175","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.chom.2020.10.003","article-title":"Ultra-low dose aerosol infection of mice with mycobacterium tuberculosis more closely models human tuberculosis","volume":"29","author":"Plumlee","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.intimp.2026.116264_bb0180","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/854507","article-title":"Th1 and Th17 cells in tuberculosis: protection, pathology, and biomarkers","volume":"2015","author":"Lyadova","year":"2015","journal-title":"Mediat. Inflamm."},{"issue":"6","key":"10.1016\/j.intimp.2026.116264_bb0185","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J. Exp. Med."},{"issue":"8","key":"10.1016\/j.intimp.2026.116264_bb0190","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1002\/eji.201040433","article-title":"Enhanced protection to mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung","volume":"40","author":"Redford","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2026.116264_bb0195","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1038\/s41467-025-58115-8","article-title":"A combined adjuvant and ferritin nanocage based mucosal vaccine against Streptococcus pneumoniae induces protective immune responses in a murine model","volume":"16","author":"Nguyen","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.intimp.2026.116264_bb0200","doi-asserted-by":"crossref","first-page":"e419","DOI":"10.1002\/mco2.419","article-title":"Mycobacterium tuberculosis: immune response, biomarkers, and therapeutic intervention","volume":"5","author":"Zhuang","year":"2024","journal-title":"MedComm (2020)"},{"issue":"1","key":"10.1016\/j.intimp.2026.116264_bb0205","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/imr.12859","article-title":"The role of B cell antigen presentation in the initiation of CD4+ T cell response","volume":"296","author":"Hua","year":"2020","journal-title":"Immunol. Rev."},{"issue":"4","key":"10.1016\/j.intimp.2026.116264_bb0210","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10514","article-title":"A multivalent plasmodium falciparum circumsporozoite protein-based nanoparticle malaria vaccine elicits a robust and durable antibody response against the junctional epitope and the major repeats","volume":"8","author":"Pendyala","year":"2023","journal-title":"Bioeng. Transl. Med."},{"issue":"5","key":"10.1016\/j.intimp.2026.116264_bb0215","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1021\/acs.bioconjchem.1c00208","article-title":"Self-assembling nanoparticle vaccines displaying the receptor binding domain of SARS-CoV-2 elicit robust protective immune responses in Rhesus monkeys","volume":"32","author":"Li","year":"2021","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.intimp.2026.116264_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1307429","article-title":"Immunogenicity of PE18, PE31, and PPE26 proteins from mycobacterium tuberculosis in humans and mice","volume":"14","author":"Garc\u00eda-Bengoa","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116264_bb0225","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1355983","article-title":"Development and application of the direct mycobacterial growth inhibition assay: a systematic review","volume":"15","author":"Painter","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2026.116264_bb0230","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tube.2017.07.008","article-title":"A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development","volume":"106","author":"Pepponi","year":"2017","journal-title":"Tuberculosis (Edinb.)"},{"key":"10.1016\/j.intimp.2026.116264_bb0235","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/s12879-016-1751-4","article-title":"A new tool for tuberculosis vaccine screening: ex vivo mycobacterial growth inhibition assay indicates BCG-mediated protection in a murine model of tuberculosis","volume":"16","author":"Zelmer","year":"2016","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.intimp.2026.116264_bb0240","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/193923","article-title":"Cellular and humoral mechanisms involved in the control of tuberculosis","volume":"2012","author":"Zu\u00f1iga","year":"2012","journal-title":"Clin. Dev. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2026.116264_bb0245","article-title":"Comparison of the immunogenicity and efficacy of rBCG-EPCP009, BCG prime-EPCP009 booster, and EPCP009 protein regimens as tuberculosis vaccine candidates","volume":"11","author":"Wang","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.intimp.2026.116264_bb0250","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.mimet.2016.09.010","article-title":"A simplified mycobacterial growth inhibition assay (MGIA) using direct infection of mouse splenocytes and the MGIT system","volume":"131","author":"Yang","year":"2016","journal-title":"J. Microbiol. Methods"},{"issue":"9","key":"10.1016\/j.intimp.2026.116264_bb0255","doi-asserted-by":"crossref","DOI":"10.1128\/CVI.00142-17","article-title":"The cross-species mycobacterial growth inhibition assay (MGIA) project, 2010-2014","volume":"24","author":"Brennan","year":"2017","journal-title":"Clin. Vaccine Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2026.116264_bb0260","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1172\/JCI97508","article-title":"Mycobacterial growth inhibition is associated with trained innate immunity","volume":"128","author":"Joosten","year":"2018","journal-title":"J. Clin. Invest."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926001074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576926001074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:18:22Z","timestamp":1776770302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576926001074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":52,"alternative-id":["S1567576926001074"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116264","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel mi3 VLP nanoparticle vaccine displaying ESAT-6 -PPE57 -PPE68 -EsxV antigens exhibits superior immunogenicity and Mycobacterium tuberculosis growth inhibition","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2026.116264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116264"}}